Based on the Enzon Pharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Enzon Pharmaceuticals Inc is not available over the next 12 months. Enzon Pharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Enzon Pharmaceuticals Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Enzon Pharmaceuticals Inc’s stock price was USD 0.11. Enzon Pharmaceuticals Inc’s stock price has changed by +9.20% over the past week, +20.66% over the past month and +68.52% over the last year.
No recent analyst target price found for Enzon Pharmaceuticals Inc
No recent average analyst rating found for Enzon Pharmaceuticals Inc
Company Overview Enzon Pharmaceuticals Inc
Enzon Pharmaceuticals, Inc., together with its subsidiaries, does not have significant operations. Previously, it sells its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey. Read Less
Enzon Pharmaceuticals, Inc., together with its subsidiaries, does not have significant operations. Previously, it sells its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC O...Read More
Frequently Asked Questions About Enzon Pharmaceuticals Inc (ENZN) Stock
Stock Target Advisor's fundamental analysis for Enzon Pharmaceuticals Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on ENZN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ENZN's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ENZN's stock to indicate if its overvalued.
The last closing price of ENZN's stock was USD 0.11.
The most recent market capitalization for ENZN is USD 7.42M.
Unfortunately we do not have enough analyst data on ENZN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Enzon Pharmaceuticals Inc's stock.
As per our most recent records Enzon Pharmaceuticals Inc has 0 Employees.
Enzon Pharmaceuticals Inc's registered address is 20 Commerce Drive, Cranford, NJ, United States, 07016.
You can get more information about it from Enzon Pharmaceuticals Inc's website at https://enzon.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Enzon Pharmaceuticals Inc (ENZN) Stock
Stock Target Advisor's fundamental analysis for Enzon Pharmaceuticals Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on ENZN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ENZN's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ENZN's stock to indicate if its overvalued.
The last closing price of ENZN's stock was USD 0.11.
The most recent market capitalization for ENZN is USD 7.42M.
Unfortunately we do not have enough analyst data on ENZN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Enzon Pharmaceuticals Inc's stock.
As per our most recent records Enzon Pharmaceuticals Inc has 0 Employees.
Enzon Pharmaceuticals Inc's registered address is 20 Commerce Drive, Cranford, NJ, United States, 07016.
You can get more information about it from Enzon Pharmaceuticals Inc's website at https://enzon.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ENZN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
